Analyst Upgrades: TASER International, Inc., Shake Shack Inc, and Humana Inc

Analysts upwardly revised their ratings and price targets on TASER International, Inc. (NASDAQ:TASR), Shake Shack Inc (NYSE:SHAK), and Humana Inc (NYSE:HUM)

Josh Selway
Nov 10, 2016 at 9:14 AM
facebook twitter linkedin


Analysts are weighing in on stun gun producer TASER International, Inc. (NASDAQ:TASR), burger joint Shake Shack Inc (NYSE:SHAK), and insurance stock Humana Inc (NYSE:HUM). Here's a quick roundup of today's bullish brokerage notes for TASR, SHAK, and HUM.

  • TASR is set to rally thanks to the company's better-than-expected earnings results. The shares are up 7% ahead of the open, as Craig-Hallum and J.P. Morgan Securities increased their respective price targets to $35 and $32 -- both in annual-high territory. Though TASER International, Inc. has pulled back since flirting with the $30 mark back in August, the shares recently found firm support from their 200-day and 320-day moving averages, closing Wednesday at $23.67. Short sellers, meanwhile, may be reconsidering their positions. Short interest represents more than one-fifth of the stock's float, and equals one week's worth of buying power, at TASR's average daily volumes. 
  • SHAK is also set for a post-earnings burst, with the shares gaining 10% in pre-market action, after the company posted a third-quarter profit that blew past estimates, while also raising its full-year revenue outlook. Shake Shack Inc was in need of a positive development, with shareholders watching the stock dive 22.5% since its most recent high of $42.94 in August, last seen at $33.26. Turning to the analyst front, most are bearish on SHAK, with just four of 11 recommending investors buy the stock. Overnight, though, Wedbush raised its price target to $30, and Jefferies bumped its price target to $38. 
  • It's truly been an up-and-down year for HUM, rising to $190 in June, only to fall to $150 weeks later, with several large moves coming before and after. In fact, the shares have gained 11% this week alone to trade at $186 -- avoiding the broader healthcare swoon in the process -- and have edged 1.1% higher ahead of the open yet again. Helping Humana Inc this morning is an upgrade to "overweight" from "neutral" at J.P. Morgan Securities, which also raised its price target to $202 from $163, representing an annual high. In the meantime, options traders have been bracing for a pullback. At the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), HUM has posted a 10-day put/call volume ratio of 9.36, ranking in the high 88th annual percentile. 
Don't miss the market's next move! Sign up now for Schaeffer's Midday Market Check

A Schaeffer's exclusive!

The Expert's Guide

Access your FREE trading earnings guide for Q3 before it's too late!


  
 

Partnercenter